期刊文献+

急性冠状动脉综合征患者血清高迁移率族蛋白-1水平与左室射血分数相关性研究 被引量:3

Association of serum high mobility group box-1 level with left ventricular ejection fraction in patients with acute coronary syndrome
原文传递
导出
摘要 目的评价血清高迁移率族蛋白-1(high mobility group box-1,HMGB-1)与急性冠状动脉综合征患者左室射血分数的关系。方法急性冠状动脉综合征患者121例(ACS组)及体检健康者42例(对照组),比较2组血清HMGB-1水平及左室射血分数、左心室舒张期末径、左心室收缩期末径及二尖瓣口血流E/A峰值比。结果 ACS组患者血清HMGB-1水平明显高于对照组(P<0.05);与对照组比较,ACS组左室射血分数及E/A明显降低,而左心室收缩期末径明显增大(P<0.05);血清HMGB-1水平与左室射血分数呈明显负相关(r=-0.299,P<0.01)。结论血清HMGB-1水平可反映急性冠状动脉综合征患者的左室射血分数,有助于评价其心脏收缩功能。 Objective To investigate the association of high mobility group box-1 (HMGB1) level with the left ventricular ejection fraction (LVEF) in patients with acute coronary syndrome (ACS). Methods A total of 121 patients with ACS and 42 healthy controls were compared serum HMGB-1 level, LVEF, left ventricular end diastolic diameter (LVDD), left ventricular end systolic diameter (LVDS) and mitral valve E/A. Results Serum HMGB-1 level was significantly higher in ACS group than that in control group (P〈0.01). LVEF and mitral valve E/A were significantly lower, and LVDS was significantly longer in ACS group compared with control group (P〈0.05). HMGB-1 level was significantly and negatively correlated with LVEF (P〈0.01). Conclusion Serum HMGB-1 level can reflect the LVEF value, which helps to evaluate cardiac systolic function in patients with ACS.
出处 《中华实用诊断与治疗杂志》 2012年第8期753-754,共2页 Journal of Chinese Practical Diagnosis and Therapy
基金 福建省自然科学青年基金(2010J05064)
关键词 急性冠状动脉综合征 左室射血分数 高迁移率族蛋白-1 Acute coronary syndrome left ejection fraction high mobility group box-1
  • 相关文献

参考文献10

  • 1Scirica B M. Acute coronary syndrome: emerging tools for diagnosis and risk assessment[J]. J Am Coll Cardiol, 2010,55 (14) :1403-1415.
  • 2方阅,刘皋林,方敏.阿托伐他汀早期干预对非ST抬高型急性冠脉综合征患者血清高敏C反应蛋白和妊娠相关血浆蛋白-A水平的影响[J].中华实用诊断与治疗杂志,2008,22(10):721-723. 被引量:8
  • 3渠胜英,潘永瑜,姚革.老年急性冠脉综合征患者血清瘦素、TNF-α水平的变化及临床意义[J].中华实用诊断与治疗杂志,2008,22(10):748-749. 被引量:6
  • 4Yamada S, Maruyama I. HMGBI: a novel inflammatory eytokine[J].Clin Chim Acta,2007,375(1/2) :36 42.
  • 5Huang W, Tang Y, Li L. HMGBI: a potent proinflammatory cytokine in sepsis[J]. Cytokine,2010,51(2):119-126.
  • 6Anderson J L, Adams C D, Antman E M, et al. IACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non ST Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons : endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine [J].Circulation, 2007, 116 (7) : e148-304.
  • 7Haas M J, Mooradian A D. Regulation of high density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease [J]. Diabetes Metab Res Rev,2010,26(2):90-99.
  • 8Cirillo P, Giallauria F, Pacileo M, etal. Increased high mobility group box-1 protein levels are associated with impaired cardiopulmonary and echocardiographic findings after acute myocardial infarction[J].J Card Fail,2009,15(4) : 362 -367.
  • 9Kalinina N, Agrotis A, Antropova Y, et al. Increased expression of the DNA binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines[J]. Arterioscler Thromb Vasc Biol, 2004,24 ( 12 ) : 2320- 2325.
  • 10Yamada S, Yakabe K, Ishii J, etal. New high mobility group boxl assaysystem[J]. Clin Chim Acta,2006,372(1/2):173- 178.

二级参考文献7

共引文献12

同被引文献26

  • 1Pitkin S L, Maguire J J, Kuc R E, et al. Modulation of the apelin/APJ system in heart failure and atherosclerosis in man [J]. Br J Pharmacol, 2010,160(7) : 1785-1795.
  • 2Deng Y, Scherer P E. Adipokines as novel biomarkers and regulators of the metabolic syndrome[J]. Ann N Y Acad Sci, 2010,1212(11) = El-E19.
  • 3Taube A, Schlich R, Sell H, et al. Inflammation and metabolic dysfunction: links to cardiovascular diseases[J]. Am J Physiol Heart Circ Physiol,2012,302(11) :H2148-2165.
  • 4Amasyali B, Kilic A, Celik T, et al. A new frame in thromboembolic cardiovascular disease: adipocytokine[J]. Int J Cardiol, 2010,139(1) : 100-102.
  • 5Castan-Laurell I, Dray C, Knauf C, et al. Apelin, a promising target for type 2 diabetes treatment [J]. Trends Endocrinol Metab,2012,23(5) :234 -241.
  • 6Tasci I. Apelin, prediabetes and atherosclerosis[J]. Exp Clin Endocrinol Diabetes,2011,119(8) :457-458.
  • 7Li Z, Bai Y, Hu J. Reduced apelin levels in stable angina[J]. Intern Med,2008,47(22) :1951- 1955.
  • 8Zheng-Gang Luan,Hao Zhang,Ping-Ting Yang,Xiao-Chun Ma,Cheng Zhang,Ren-Xuan Guo.??HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells(J)Immunobiology . 2009 (12)
  • 9High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart(J)Circulation . 2008 (25)
  • 10Takeno M,Y asuda S,O isuka Y e t a l.Impact of m etabolic syndrome on the long-temr survival of patients with acute myocardial infarction. Circulation Journal . 2013

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部